News

For new and old investors, taking full advantage of the stock market and investing ... its share price will decline as well. Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, ...
GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine segment. See why the stock is a Buy.
GSK’s Price Performance, Valuation & Estimate Movement. GSK stock has risen 20.1% year to date compared with an increase of 4.0% for the industry. The stock has also outperformed the sector and ...
European stocks ended the week with a small decline, as GSK Plc’s shares weighed on the healthcare sector on a busy earnings day.
The Nikkei 225 has fallen 0.2%, while the Hang Seng index is 0.3% higher. The FTSE 100 index is seen opening about 21 points ...
In other GSK news, insider Emma Walmsley sold 5,473 shares of the company’s stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of GBX 1,449 ($19.63), for a ...
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. Stock to Watch: GSK (GSK) GSK has three segments: Specialty Medicines (HIV, Oncology, Immunology/Respiratory ...